Lung Dose in Patients Treated With Yttrium-90 for Hepatocellular Carcinoma

Status Completed

Clinical Trial Summary

To Calculate the amount radiation the lung receives in patients receiving Yttrium-90 for Liver Cancer.

Clinical Trial Description

To calculate the delivered lung dose using quantitative volumetric analysis in a cohort of patients with unresectable hepatocellular carcinoma who undergo selective internal radiation therapy (SIRT) with Yttrium-90 glass microspheres (TheraSphere®)-and compare this analysis to the lung dose estimated by established criteria. In addition, this study, will summarize the pre and post-treatment clinical data to describe the URMC Y-90 experience. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02489838
Study type	Observational
Source	University of Rochester
Contact
Status	Completed
Phase
Start date	February 3, 2012
Completion date	August 7, 2019

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03651154` - Hypovolemic Phlebotomy to Reduce Blood Transfusions in Major Hepatic Resections	N/A
Not yet recruiting	`NCT03592550` - The eValuation of Image Guidance of Stereotactic Body Radiotherapy Using Ultrasound: Assessment in Liver
Not yet recruiting	`NCT02521129` - A New Track Ablation Device for Liver Biopsy: A Feasibility Study	Phase 1/Phase 2
Not yet recruiting	`NCT02168608` - Remote Ischemia Precondition (RIPC) for Hepatic Protection in Patients Undergoing Hepatectomy	N/A
Enrolling by invitation	`NCT01465425` - Extracolonic Findings on Computed Tomography (CT) Colonography
Active, not recruiting	`NCT01177007` - Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors	Phase 2
Completed	`NCT00788697` - SonoVue®-Enhanced Ultrasound Versus Unenhanced US for Focal Liver Lesion Characterization	Phase 3
Recruiting	`NCT01564810` - Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer	Phase 4
Completed	`NCT00094003` - Study of NS-9 in Patients With Liver Metastases	Phase 1
Terminated	`NCT00051532` - Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma	N/A
Completed	`NCT00001587` - A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver	Phase 1
Completed	`NCT00222664` - Qidong Hepatitis B Intervention Study	Phase 4
Recruiting	`NCT04518852` - TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC	Phase 2
Completed	`NCT03289273` - Observational Study to Evaluate, Under Real-world Practice Conditions, the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC)
Terminated	`NCT03349255` - Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma	Phase 1
Recruiting	`NCT05068180` - Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients	Phase 4
Recruiting	`NCT03715517` - Spinal Anesthesia For Enhanced Recovery After Liver Surgery	N/A
Terminated	`NCT03685591` - PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors	Phase 1
Terminated	`NCT01744054` - Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization	Phase 1
Active, not recruiting	`NCT02969096` - Clinical Study of Targeted Cryoablation Therapy in the Treatment of Hepatic Carcinoma	Phase 2